Stem-cell-based embryo models (SCBEMs) are opening new possibilities in developmental biology, reproductive science and translational research, alongside important progress in ethics and governance.
As models become more complex and their uses expand, questions concerning their appropriate scientific justification and moral value – and related questions of consent, culture limits and public trust – are also evolving. No single discipline can answer these questions alone.
National approaches to this area also differ substantially, creating both opportunities for learning and challenges for international research. Together, these developments make a strong case for sustained dialogue and collaboration across disciplines and borders.
From Geneva to Leiden
In May 2025, a group of interdisciplinary SCBEM experts met at the Brocher Foundation in Geneva, Switzerland, to discuss the challenges. That three-day meeting led to a new network called EMERGE (Embryo Model Ethics, Research, Governance and Engagement). The Geneva discussions focused on articulating key problems. The next step was to identify shared priorities, and where EMERGE could contribute.
EMERGE met again as a larger group, for a five-day workshop in September 2026 at the Lorentz Centre in Leiden, the Netherlands. That workshop brought together 44 experts from diverse disciplinary and professional backgrounds, including biomedical and social scientists, ethicists, lawyers, regulators, philosophers and policymakers from Africa, Asia, Europe, North America and Oceania.

The workshop was financially supported by ZonMw and by the Science and Technology Policy programme at Rice University's Baker Institute, with substantial in-kind support from the Lorentz Centre. This enabled participation across a broad range of disciplines, jurisdictions, and career stages.
Five days at the Lorentz Centre
The Lorentz Centre workshop was designed to be highly participatory. There were short plenary talks and expert panels, but most of the work happened in small interdisciplinary breakout groups, priority-setting exercises, live rapporteur sessions and whole-group syntheses.
Each day had its own purpose. The first day mapped the scientific and governance landscape, while the second looked at moral, legal and developmental boundaries. The third day covered international and cross-border issues, including a session on the scientific, ethical and governance challenges that may lie ahead. On the fourth day, the focus moved from analysis to recommendations, public dialogue and plans for joint papers. The final day was used to agree on EMERGE's vision and mission, and to assign people to lead specific projects.
An important insight was that SCBEM research is moving from building and validating models toward using models in IVF research, toxicology, drug screening and tissue generation. Additionally, implantation models are becoming increasingly complex, while substantial experimental variability complicates claims about what a model can reliably do.
These advances raise important ethical and governance questions. If models are becoming more useful, more complex and less easily classified, should oversight become less concerned with labels and fixed time limits, and more concerned with function, developmental features, intended use and emergent capacities?
Advances in SCBEM research also raise questions about validation, consent, moral value, transplantation, public engagement, and how governance can remain proportionate and adaptive as the science changes. An important consideration is whether and how governance of biotechnology can address the field as a whole, rather than reacting to each new technology in turn.
EMERGE's vision and mission
On the final day, participants discussed the vision and mission of the network.
- EMERGE strives for a world in which SCBEM research responsibly advances health and knowledge.
- EMERGE aims to facilitate the trustworthy advancement of SCBEM research through global dialogue and interdisciplinary collaboration, promoting scientific excellence, robust ethical consideration, meaningful societal engagement and agile governance.
Our mission reflects a belief that ran through the whole week – the belief that scientific progress, ethical scrutiny, responsive governance and societal engagement are not in competition. All four are needed, if the field is to advance responsibly.
Next steps for the network
The workshop produced a concrete programme of work. Participants drafted a list of priorities to safeguard responsible SCBEM research, and identified what EMERGE can do to help. International and interdisciplinary subgroups will now write a series of papers on several of these priority questions.
The Leiden meeting also identified two practical next steps for the EMERGE network.
- EMERGE plans to facilitate a regulator network, to strengthen links between oversight bodies across jurisdictions and between regulators and researchers.
- EMERGE aims to create comparative 'regulation snapshots' – that is, overviews of how different countries govern research involving SCBEMs, to help stakeholders navigate cross-jurisdictional differences and identify areas of convergence.
Looking ahead
The field is moving quickly. Governance frameworks will need to be anticipatory, grounded in science, and ethically and socially informed.
EMERGE aims to provide a forum where questions raised by SCBEM research can be addressed together, across disciplines and borders. If you want to learn more, please visit our website. If you have questions or ideas for collaboration, please get in touch.
Written by Nienke de Graeff, Emma Cave, Megan Munsie, Martin Buck, Naomi Moris and Nicolas Rivron, on behalf of the EMERGE network.




